INVA Innoviva Inc
P/E
4.918
Forward P/E
8.95
Price/Sales
3.456
Beta
0.334
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🟢 Innoviva is trading 6.47% up in pre-market with catalyst still unclear
Innoviva is trading at $22.71, up 6.47% in pre-market; the catalyst remains unclear. - No company-specific announcement, earnings release, filing, or analyst...
🔴 Innoviva is trading 10.25% down in pre-market; no company-specific announcement identified
Innoviva is trading 10.25% down at $19.00, with no new company-specific announcement identified for August 26, 2026. - Investor relations lists its latest...
🔴 Innoviva is trading 8.1% down in pre-market after $161.0 million investment fair-value decline
Innovava is trading at $19.00 (-8.12%) with no new company-specific announcement identified for August 11, 2026. • The August 5 earnings report showed $119.6...
Innoviva second quarter 2026 revenue rose 19% behind 46% growth in specialty therapeutics sales
Innoviva reported second quarter 2026 total revenue of $119.6 million, a 19% increase year-over-year. While the core royalty portfolio provided stable cash...